MDXH.BR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 Dec 2023 @ 11:35):

Stats
Today's Volume	14 079.00
Average Volume	40 428.00
Market Cap	85.63M
EPS	$-0.400 ( 2023-11-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.581
ATR14	$0.202 (6.69%)

Volume Correlation

Long: 0.04 (neutral)

Short: -0.01 (neutral)

Signal:(52.307) Neutral

MDxHealth SA Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MDxHealth SA Correlation - Currency/Commodity

-0.16
( neutral )

-0.10
( neutral )

0.00
( neutral )

0.14
( neutral )

-0.06
( neutral )

0.48
( neutral )

MDxHealth SA Financials

Annual	2022
Revenue:	$37.05M
Gross Profit:	$19.22M (51.87 %)
EPS:	$-0.320

Q3	2023
Revenue:	$19.35M
Gross Profit:	$12.55M (64.87 %)
EPS:	$-0.0400

Q2	2023
Revenue:	$16.75M
Gross Profit:	$9.99M (59.66 %)
EPS:	$-0.0454

Q1	2023
Revenue:	$14.70M
Gross Profit:	$8.72M (59.29 %)
EPS:	$-0.0628

Financial Reports:

No articles found.

MDxHealth SA

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.